PlainBillCongress, translated.Legislation. Context. Public interest.Congressional Research Service
Version 00 · Introduced in House · Aug 2, 2001
Drug Access Act of 2001 - Amends the Federal Food, Drug, and Cosmetic Act to authorize a charitable health care entity to receive a drug sample donated by specified individuals or by another such entity for dispensing to a patient of the charitable institution, and to donate a drug sample to another such entity for dispensing to its patients, if: (1) delivery of the sample is completed by mail or common carrier, collection by an authorized agent or employee of the recipient entity, or personal delivery by a licensed practitioner or an agent or employee of the donating entity; (2) the entity receiving the sample executes a written receipt upon its delivery and provides for the return of the receipt to the donating entity; (3) the donated drug sample received by the entity is in its original, unopened packaging with its labeling intact; and (4) before dispensing such sample to a patient, the sample is examined by a licensed practitioner or registered pharmacist to confirm that the sample is not adulterated or misbranded.
People & committees
Rep. Burr, Richard [R-NC-5] · R–NC
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Primary sources
Text links open the official source. We currently store references to these documents.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Aug 19, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze H.R.2740 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine H.R.2740 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine H.R.2740 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine H.R.2740 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.